Drugs / Y-4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06935721 | Mar → May 2025 overdue | — | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Y-4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06935721 ↗ |
| Route | Oral | “Single oral administration in the state of fasting state” NCT06935721 ↗ |